Use of maternal GHb concentration to estimate the risk of congenital anomalies in the offspring of women with prepregnancy diabetes

Diabetes Care

Volumn 30, Issue 7, 2007, Pages 1920-1925

  Guerin, Andrea ^a   Nisenbaum, Rosane ^b   Ray, Joel G ^b  

^a WESTERN UNIVERSITY   (Canada)

^b ST MICHAEL'S HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOSYLATED HEMOGLOBIN; HEMOGLOBIN A1C;

CLINICAL TRIAL; CONGENITAL MALFORMATION; DIABETES MELLITUS; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HUMAN; MATERNAL CARE; PREGNANCY OUTCOME; PREPREGNANCY CARE; REVIEW; RISK ASSESSMENT;

ABNORMALITIES; ADULT; COHORT STUDIES; DIABETES COMPLICATIONS; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HEMOGLOBINS; HUMANS; HYPERGLYCEMIA; PREGNANCY; PREGNANCY IN DIABETICS; RISK ASSESSMENT;

EID: 34447124337     PISSN: 01495992     EISSN: 01495992     Source Type: Journal    
DOI: 10.2337/dc07-0278     Document Type: Review

References (28)

1. Ylinen K, Aula P, Stenman UH, Kesaniemi-Kuokkanen T, Teramo K: Risk of minor and major fetal malformations in diabetics with high hemoglobin A1C values in early pregnancy. Br Med J (Clin Res Ed) 289:345-346, 1984
2. Casson IF, Clarke CA, Howard CV, McKendrick O, Pennycook S, Pharoah PO, Platt MJ, Stanisstreet M, van Velszen D, Walkinshaw S: Outcomes of pregnancy in insulin dependent diabetic women: results of a five year population cohort study. BMJ 315:275-278, 1997
3. Macintosh MC, Fleming KM, Bailey JA, Doyle P, Modder J, Acolet D, Golightly S, Miller A: Perinatal mortality and congenital anomalies in babies of women with type 1 or type 2 diabetes in England, Wales, and Northern Ireland: population based study. BMJ 333:177, 2006
4. Sadler TW, Hunter ES 3rd, Balkan W, Horton WE Jr: Effects of maternal diabetes on embryogenesis. Am J Obstet Perinaol 5:319-326, 1988
5. Eriksson UJ, Borg LA, Forsberg H, Styrud J: Diabetic embryopathy: studies with animal and in vitro models. Diabetes 40 (Suppl. 2):94-98, 1991
6. Key TC, Giuffrida R, Moore TR: Predictive value of early pregnancy glycohemoglobin in the insulin-treated diabetic patient. Am J Obstet Gynecol 156:1096-1100, 1987
7. Miodovnik M, Mimouni F, Dignan PS, Berk MA, Ballard JL, Siddiqi TA, Khoury J, Tsang RC: Major malformations in infants of IDDM women: vasculopathy and early first trimester poor glycemic control. Diabetes Care 11:713-718, 1988
8. 1 and risk for major malformation and spontaneous abortion in diabetic pregnancy. Teratology 39:225-231, 1989
9. Greene MF: Spontaneous abortions and major malformations in women with diabetes mellitus. Semin Repro Endo 17:127-136, 1999
10. Ray JG, O'Brien TE, Chan WS: Preconception care and the risk of congenital anomalies in the offspring of women with diabetes mellitus: a meta-analysis. QJM 94:435-444, 2001
11. O'Brien TE, Ray JG, Chan WS: Maternal body mass index and the risk of preeclampsia: a systematic overview. Epidemiology 14:368-374, 2003
12. Hox J: Multilevel Analysis: Techniques and Applications. Hillsdale, NJ, Lawrence Erlbaum Associates, 2002
13. Lucas MJ, Leveno KJ, Williams ML, Raskin P, Whalley PJ: Early pregnancy glycosylated hemoglobin, severity of diabetes, and fetal malformations. Am J Obstet Gynecol 161:426-431, 1989
14. Suhonen L, Hiilesmaa V, Teramo K: Glycaemic control during early pregnancy and fetal malformations in women with type 1 diabetes mellitus. Diabetologia 43:79-82, 2000
15. Kitzmiller JL, Gavin LA, Gin GD, Jovanovic-Peterson L, Main EK, Zigrang WD: Preconception care of diabetes: glycemic control prevents congenital anomalies. JAMA 265:731-736, 1991
16. Mills JL, Knopp RH, Simpson JL, Jovanovic-Peterson L, Metzger BE, Holmes LB, Aarons JH, Brown Z, Reed GF, Bieber FR, et al.: Lack of relation of increased malformation rates in infants of diabetic mothers to glycemic control during organogenesis. N Engl J Med 318:671-676, 1998
17. Hoyme HE: Minor anomalies: diagnostic clues to aberrant human morphogenesis. Genetica 89:307-315, 1993
18. Hillman N, Herranz L, Grande C, Vaquero PM, Pallardo LF: What is the relative contribution of blood glucose levels at different time points of the day to HbA1c in type 1 diabetes? Diabet Med 21:468-470, 2004
19. Sachs DB: Global harmonization of hemoglobin A1c. Clin Chem 51:681-683, 2000
20. Manley S, John WG, Marshall S: Introduction of IFCC reference method for calibration of HbA1C: implications for clinical care. Diabet Med 21:673-676, 2004
21. NGSP Clinical Advisory Committee: Harmonizing glycated hemoglobin testing: a better A1c test means better diabetes care [article online], 2006. Available from http://www.ngsp.org/prog/IFCCstd.pdf. Accessed 21 May 2007
22. Rosenn B, Miodovnik M, Combs A, Khoury J, Siddiqi TA: Glycemic thresholds for spontaneous abortion and congenital malformations in insulin-dependent diabetes mellitus. Obstet Gynecol 84:515-520, 1994
23. Mironiuk M, Kietlinska Z, Jezierska-Kaspryk K, Piekosz-Orzechowska B: A class of diabetes in the mother, glycemic control in early pregnancy and occurance of congenital malformations in newborn infants. Clin Exp Obstet and Gynecol 24:193-197, 1997
24. Hanson U, Persson B, Thunell S: Relationship between hemoglobin A1c in early type 1 (insulin-dependent) diabetic pregnancy and the occurance of spontaneous abortion and fetal malformation in Sweden. Diabetologia 33:100-104, 1990
25. Nielsen GL, Moller M, Sorensen HT: HbA1c in early diabetic pregnancy and pregnancy outcomes: a Danish population-based cohort study of 573 pregnancies in women with type 1 diabetes. Diabetes Care 29:2612-2616, 2006
26. McLeod L, Ray JG: Prevention and detection of diabetic embryopathy. Commun Genet 5:33-39, 2002
27. Feig DS, Palda VA: Type 2 diabetes in pregnancy: a growing concern. Lancet 359:1690-1692, 2002
28. Watkins ML, Rasmussen SA, Honein MA, Botto LD, Moore CA: Maternal obesity and risk for birth defects. Pediatrics 111:1152-1158, 2003